Back

Natural progression of rheumatic aortic valve disease following rheumatic mitral valve intervention: 16-year single center experience

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Advancing knowledge in valvular heart disease: the role of registries Aortic Valve Disease, Other ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Seok Hyun Kim

Pusan National University Yangsan Hospital, Yangsan (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Overview of the risk of myocardial infarction in patients with aortic stenosis: insights from the VALVENOR Registry.
Professor G. Lemesle (Lille, FR)
Abstract Slides Video
Presentation thumbnail
Incidence, predictors and outcomes of non-home discharge following transcatheter aortic valve implantation: a multicentre Australian experience. The NHD TAVI study.
Doctor A. Butala (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Gender-specific differences in severe tricuspid regurgitation. Finding from a TR multicentre CMR registry
Doctor S. Rodriguez Diego (Salamanca, ES)
Abstract Slides Video
Presentation thumbnail
Effect of severe tricuspid regurgitation on the prognosis of patients with atrial functional mitral regurgitation: the REVEAL-AFMR registry
Doctor T. Kaneko (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Advancing knowledge in valvular heart disease: the role of registries

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Demographics and clinical outcomes of flow-gradient patterns of aortic stenosis: an analysis of the CURRENT AS Registry-2.
thumbnail
Congress Presentation
Comparative outcomes of early intervention vs. watchful waiting strategy for moderate aortic stenosis by extent of extra-valvular cardiac damage
thumbnail
Congress Presentation
Prognostic predictors after TAVI in patients with severe aortic stenosis and concomitant aortic regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources